HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter L Choyke Selected Research

Monoclonal Antibodies

6/2022Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.
8/2021Near infrared photoimmunotherapy for cancers: A translational perspective.
5/2021Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy.
12/2020Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy.
9/2020Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors.
8/2020Conjugation Ratio, Light Dose, and pH Affect the Stability of Panitumumab-IR700 for Near-Infrared Photoimmunotherapy.
1/2020Wound healing after excision of subcutaneous tumors treated with near-infrared photoimmunotherapy.
1/2020Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs).
12/2019Near-infrared photoimmunotherapy through bone.
1/2019Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter L Choyke Research Topics

Disease

260Neoplasms (Cancer)
12/2022 - 01/2002
87Prostatic Neoplasms (Prostate Cancer)
10/2022 - 04/2009
35Neoplasm Metastasis (Metastasis)
01/2022 - 09/2006
23Ovarian Neoplasms (Ovarian Cancer)
11/2018 - 07/2006
9Breast Neoplasms (Breast Cancer)
09/2022 - 05/2004
6Adenocarcinoma
01/2021 - 11/2007
5Hepatocellular Carcinoma (Hepatoma)
12/2020 - 01/2015
4Head and Neck Neoplasms (Head and Neck Cancer)
04/2022 - 01/2021
4Melanoma (Melanoma, Malignant)
01/2022 - 07/2008
4Necrosis
01/2020 - 01/2014
4Infections
01/2020 - 08/2006
4Carcinoma (Carcinomatosis)
01/2019 - 09/2006
4Renal Cell Carcinoma (Grawitz Tumor)
01/2016 - 05/2004
4Inflammation (Inflammations)
11/2014 - 10/2007
3Hypoxia (Hypoxemia)
01/2020 - 05/2004
3Kidney Neoplasms (Kidney Cancer)
01/2020 - 01/2002
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2019 - 10/2017
3Lymphoma (Lymphomas)
11/2016 - 11/2005
3Lymphatic Metastasis
01/2016 - 05/2004
3Carcinogenesis
02/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

41Monoclonal AntibodiesIBA
06/2022 - 04/2007
33AntigensIBA
10/2022 - 05/2007
28Prostate-Specific Antigen (Semenogelase)IBA
01/2022 - 04/2007
27AntibodiesIBA
12/2022 - 05/2007
23Coloring Agents (Dyes)IBA
12/2022 - 11/2006
21Contrast MediaIBA
09/2018 - 03/2002
19ErbB Receptors (EGF Receptor)IBA
11/2021 - 04/2007
18Proteins (Proteins, Gene)FDA Link
12/2022 - 08/2008
17Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2006
15RhodaminesIBA
11/2018 - 11/2006
14LigandsIBA
05/2022 - 07/2006
14Trastuzumab (Herceptin)FDA Link
01/2021 - 05/2007
14Pharmaceutical PreparationsIBA
01/2020 - 09/2003
14Photosensitizing Agents (Photosensitizers)IBA
03/2016 - 11/2011
13Therapeutic UsesIBA
10/2021 - 03/2010
13AvidinIBA
12/2011 - 07/2006
12Fluorescent Dyes (Fluorescent Probes)IBA
11/2018 - 11/2006
11Panitumumab (Vectibix)FDA Link
08/2022 - 11/2009
11phthalocyanineIBA
06/2022 - 11/2011
11Radioisotopes (Radionuclides)IBA
07/2021 - 04/2007
10Galactose (Galactopyranose)FDA LinkGeneric
11/2016 - 09/2007
9Biological ProductsIBA
10/2021 - 08/2009
8Indicators and Reagents (Reagents)IBA
10/2017 - 05/2004
7Cetuximab (Erbitux)FDA Link
08/2022 - 04/2007
7Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 02/2009
62- (3- (1- carboxy- 5- ((6- fluoropyridine- 3- carbonyl)amino)pentyl)ureido)pentanedioic acidIBA
05/2022 - 10/2017
6EnzymesIBA
11/2018 - 08/2013
6ferric oxide (iron oxide)IBA
09/2018 - 07/2011
6LectinsIBA
11/2016 - 07/2006
6GadoliniumIBA
11/2014 - 06/2005
6Dendrimers (Dendrons)IBA
07/2011 - 04/2004
5Immune Checkpoint InhibitorsIBA
06/2022 - 01/2019
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 10/2014
5AcidsIBA
10/2021 - 04/2007
5Glucose (Dextrose)FDA LinkGeneric
01/2020 - 02/2010
54,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2019 - 09/2006
5LuciferasesIBA
12/2017 - 08/2012
5Serum AlbuminIBA
11/2016 - 09/2007
4Neoplasm Antigens (Tumor Antigens)IBA
12/2022 - 01/2019
4Immunoglobulin FragmentsIBA
10/2022 - 03/2011
4FluoridesIBA
01/2022 - 11/2018
4silicon phthalocyanineIBA
10/2021 - 11/2018
4Hormones (Hormone)IBA
10/2021 - 01/2010
4GlypicansIBA
12/2020 - 01/2015
4Immunoconjugates (Immunoconjugate)IBA
01/2020 - 09/2007
4Peptides (Polypeptides)IBA
10/2019 - 03/2007
4Immunoglobulin G (IgG)IBA
01/2019 - 04/2014
4Sodium Fluoride (Ossin)FDA Link
06/2018 - 09/2011
4Red Fluorescent ProteinIBA
11/2016 - 11/2007
4GalactosamineIBA
08/2008 - 09/2007
3Surface Antigens (Surface Antigen)IBA
10/2022 - 06/2009
3DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2019
3AndrogensIBA
12/2021 - 01/2019
3VaccinesIBA
01/2020 - 07/2007
3Ferrosoferric Oxide (Magnetite)FDA Link
01/2020 - 07/2015
3Epidermal Growth Factor (EGF)IBA
06/2018 - 11/2007
3Capsules (Microcapsules)IBA
01/2017 - 10/2015
3Fluconazole (Zonal)FDA LinkGeneric
12/2015 - 01/2012
3galactosyl serum albumin-rhodamine greenIBA
03/2014 - 11/2007
3Growth Factor ReceptorsIBA
08/2012 - 03/2009
3neutravidinIBA
01/2009 - 09/2006
3Fluorescein (Funduscein)FDA LinkGeneric
09/2007 - 07/2006
2Fluorine-18IBA
05/2022 - 09/2011
2Chimeric Antigen ReceptorsIBA
01/2022 - 01/2021
2Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 01/2020
2Hematoxylin (Haematoxylon)IBA
01/2022 - 01/2020
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2021

Therapy/Procedure

104Therapeutics
08/2022 - 05/2003
21Prostatectomy (Retropubic Prostatectomy)
10/2021 - 11/2011
14Immunotherapy
12/2022 - 01/2013
9Drug Therapy (Chemotherapy)
09/2022 - 09/2007
8Radiotherapy
01/2022 - 01/2014
7Castration
11/2021 - 06/2013
6Lasers (Laser)
04/2022 - 07/2002
5Phototherapy (Light Therapy)
05/2021 - 07/2016
3Aftercare (After-Treatment)
12/2021 - 01/2020
3Operative Time
01/2017 - 10/2002
3Precision Medicine
11/2016 - 03/2012
3Nephrectomy
01/2008 - 10/2002
2Molecular Targeted Therapy
09/2022 - 03/2012